Hiroaki Kikukawa
- Urology top 5%
- Pulmonary and Respiratory Medicine
- Epidemiology
- Radiology, Nuclear Medicine and Imaging
- Rheumatology
- Co-authors
- Shoichi UedaMasaki YoshidaMakoto YonoHiroshi SeshitaAkito InadomeWataru TakahashiYuki WadaYoshihiro Wada
- Topics
- Prostate Cancer Treatment and Research (7 papers)Radiopharmaceutical Chemistry and Applications (6 papers)Bone health and treatments (5 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Hiroaki Kikukawa
20 papers receiving 204 citations
Peers
Comparison fields: 5 of 58
- Urology 82
- Pulmonary and Respiratory Medicine 55
- Epidemiology 46
- Radiology, Nuclear Medicine and Imaging 38
- Rheumatology 36
Countries citing papers authored by Hiroaki Kikukawa
This map shows the geographic impact of Hiroaki Kikukawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Kikukawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Kikukawa more than expected).
Fields of papers citing papers by Hiroaki Kikukawa
This network shows the impact of papers produced by Hiroaki Kikukawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Kikukawa. The network helps show where Hiroaki Kikukawa may publish in the future.
Co-authorship network of co-authors of Hiroaki Kikukawa
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Kikukawa. A scholar is included among the top collaborators of Hiroaki Kikukawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Kikukawa. Hiroaki Kikukawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 0 | |
| 3 | 18 | |
| 4 | 3 | |
| 5 | 8 | |
| 6 | 11 | |
| 7 | 19 | |
| 8 | 1 | |
| 9 | 4 | |
| 10 | 4 | |
| 11 | 5 | |
| 12 | 10 | |
| 13 | 2 | |
| 14 | 9 | |
| 15 | [Pharmacokinetics of cisplatin and methotrexate in a patient suffering from advanced ureteral tumor accompanied by chronic renal failure, undergoing combined hemodialysis and systemic M-VAC chemotherapy]. | 10 |
| 16 | 42 | |
| 17 | 10 | |
| 18 | 8 | |
| 19 | Comparison of the effects of various anticholinergic drugs on human isolated urinary bladder. | 37 |
| 20 | 2 |
About Hiroaki Kikukawa
Hiroaki Kikukawa is a scholar working on Urology, Oncology and Pulmonary and Respiratory Medicine, having authored 21 papers that have together received 210 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (7 papers), Radiopharmaceutical Chemistry and Applications (6 papers) and Bone health and treatments (5 papers). The work is most often cited by research in Urology (82 citations), Applied Microbiology and Biotechnology (7 citations) and Molecular Medicine (13 citations). Hiroaki Kikukawa has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Shoichi Ueda, Masaki Yoshida, Makoto Yono, Hiroshi Seshita, Akito Inadome, Wataru Takahashi, Wataru Takahashi, Yuki Wada, Yoshihiro Wada and Kenichi Kitani. Their work appears in journals such as Journal of Clinical Oncology, Life Sciences and European Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.